FMP

FMP

Enter

PAHC - Phibro Animal Health...

photo-url-https://images.financialmodelingprep.com/symbol/PAHC.png

Phibro Animal Health Corporation

PAHC

NASDAQ

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

24.12 USD

1.65 (6.84%)

Operating Data

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

800.4M

833.4M

942.3M

977.89M

1.02B

1.08B

1.15B

1.22B

1.3B

1.38B

Revenue %

-

4.12

13.07

3.78

4.07

6.26

6.26

6.26

6.26

Ebitda

102.16M

105.5M

114.82M

116.63M

84.61M

125.11M

132.94M

141.26M

150.1M

159.5M

Ebitda %

12.76

12.66

12.18

11.93

8.31

11.57

11.57

11.57

11.57

Ebit

69.81M

73.61M

82.11M

82.62M

48.43M

85.38M

90.72M

96.4M

102.43M

108.85M

Ebit %

8.72

8.83

8.71

8.45

4.76

7.9

7.9

7.9

7.9

Depreciation

32.34M

31.89M

32.7M

34.01M

36.18M

39.73M

42.22M

44.86M

47.67M

50.65M

Depreciation %

4.04

3.83

3.47

3.48

3.55

3.67

3.67

3.67

3.67

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

91.34M

93.21M

91.25M

81.28M

114.61M

112.15M

119.17M

126.63M

134.55M

142.97M

Total Cash %

11.41

11.18

9.68

8.31

11.26

10.37

10.37

10.37

10.37

Receivables

126.52M

146.85M

166.54M

163.48M

169.45M

182.69M

194.12M

206.27M

219.18M

232.9M

Receivables %

15.81

17.62

17.67

16.72

16.65

16.89

16.89

16.89

16.89

Inventories

196.66M

216.31M

259.16M

277.57M

265.91M

286.65M

304.6M

323.66M

343.92M

365.44M

Inventories %

24.57

25.96

27.5

28.38

26.13

26.51

26.51

26.51

26.51

Payable

62.27M

68.36M

95.6M

73.85M

85.57M

91.03M

96.72M

102.78M

109.21M

116.04M

Payable %

7.78

8.2

10.14

7.55

8.41

8.42

8.42

8.42

8.42

Cap Ex

-34.05M

-29.32M

-37.04M

-51.79M

-41.24M

-45.53M

-48.38M

-51.41M

-54.62M

-58.04M

Cap Ex %

-4.25

-3.52

-3.93

-5.3

-4.05

-4.21

-4.21

-4.21

-4.21

Weighted Average Cost Of Capital

Price

24.12

Beta

Diluted Shares Outstanding

40.52M

Costof Debt

4.18

Tax Rate

After Tax Cost Of Debt

0.93

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

525.46M

Total Equity

977.41M

Total Capital

1.5B

Debt Weighting

34.96

Equity Weighting

65.04

Wacc

5.36

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

800.4M

833.4M

942.3M

977.89M

1.02B

1.08B

1.15B

1.22B

1.3B

1.38B

Ebitda

102.16M

105.5M

114.82M

116.63M

84.61M

125.11M

132.94M

141.26M

150.1M

159.5M

Ebit

69.81M

73.61M

82.11M

82.62M

48.43M

85.38M

90.72M

96.4M

102.43M

108.85M

Tax Rate

77.87

77.87

77.87

77.87

77.87

77.87

77.87

77.87

77.87

77.87

Ebiat

42.21M

60.2M

55.85M

49.82M

10.72M

49.98M

53.11M

56.43M

59.96M

63.72M

Depreciation

32.34M

31.89M

32.7M

34.01M

36.18M

39.73M

42.22M

44.86M

47.67M

50.65M

Receivables

126.52M

146.85M

166.54M

163.48M

169.45M

182.69M

194.12M

206.27M

219.18M

232.9M

Inventories

196.66M

216.31M

259.16M

277.57M

265.91M

286.65M

304.6M

323.66M

343.92M

365.44M

Payable

62.27M

68.36M

95.6M

73.85M

85.57M

91.03M

96.72M

102.78M

109.21M

116.04M

Cap Ex

-34.05M

-29.32M

-37.04M

-51.79M

-41.24M

-45.53M

-48.38M

-51.41M

-54.62M

-58.04M

Ufcf

-220.41M

28.88M

16.21M

-5.06M

23.06M

15.66M

23.27M

24.72M

26.27M

27.91M

Wacc

5.36

5.36

5.36

5.36

5.36

Pv Ufcf

14.86M

20.96M

21.14M

21.32M

21.5M

Sum Pv Ufcf

99.78M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

5.36

Free Cash Flow T1

28.47M

Terminal Value

847.28M

Present Terminal Value

652.59M

Intrinsic Value

Enterprise Value

752.36M

Net Debt

454.85M

Equity Value

297.52M

Diluted Shares Outstanding

40.52M

Equity Value Per Share

7.34

Projected DCF

7.34 -2.286%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep